Jaffe R, Strauss B: Late and very late thrombosis of drug-eluting stents: evolving concepts and perspectives, J Am Coll Cardiol 50:119, 2007. [An even-handed discussion of the complications following coronary artery stent placement.]
Jennette J, Falk R: Nosology of primary vasculitis, Curr Opin Rheumatol 19:10, 2007. [A classification of vasculitis based on pathogenic pathways and the vessels involved; provides a good organization to a complex and potentially confusing aspect of vascular pathology.]
Jennette JC, Falk RJ: Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease, Nat Rev Rheumatol 10:463, 2014. [A well-written and well-organized overview of the big picture in ANCA vasculitis.]
Kim FY, Marhefka G, Ruggiero NJ, et al: Saphenous vein graft disease: review of pathophysiology, prevention, and treatment, Cardiol Rev 21:101, 2013. [A good overview of the pathogenesis and clinical issues of saphenous vein graft acute occlusion and chronic stenosis.]
Libby P, Lichtman AH, Hansson GK: Immune effector mechanisms implicated in atherosclerosis: from mice to humans, Immunity 38:1092, 2013. [A superb review of the experimental and clinical literature describing the role of specific and adaptive immunity in atherosclerosis pathogenesis.]
MacAlpin RN: Some observations on and controversies about coronary arterial spasm, Int J Cardiol 181:389, 2015. [A good clinical overview of coronary spasm and its sequelae.]
Michel JB, Martin-Ventura JL, Egido J, et al: Novel aspects of the pathogenesis of aneurysms of the abdominal aorta in humans, Cardiovasc Res 90:18, 2011. [A good discussion of the molecular pathways underlying human abdominal aortic aneurysm formation.]
Monahan-Earley R, Dvorak AM, Aird WC: Evolutionary origins of the blood vascular system and endothelium, J Thromb Haemost 11(Suppl 1):46, 2013. [An interesting discussion of the evolutionary basis for vascular development, including cogent explanations for endothelial heterogeneity.]
Penel N, Marréaud S, Robin YM, et al: Angiosarcoma: state of the art and perspectives, Crit Rev Oncol Hematol 22:1266, 2011. [An extensive clinical summary of this aggressively malignant vascular tumor.]
Ridker P: From C-reactive protein to interleukin-6 to interleukin-1: moving upstream to identify novel targets for atheroprotection, Circ Res 118:145, 2016. [A well-written opinion piece regarding how CRP links to other inflammatory mediators, and potentially identifies therapeutic targets.] http://ebooksmedicine.net studentconsult.com
Other Causes of Myocardial Disease
Cardiac Effects of Noncardiac Neoplasms